Skip to main content

Table 2 Gene expression profiles in testicular cells before and after GnRHa treatment

From: Epigenetics, cryptorchidism, and infertility

Gene symbol

-/ + GnRHa

treatment

(RPKM)

log2FC/FDR

Molecular function

Testicular cell type expressing mRNA [9]

Class 1

KDM6A

19.9/11.3

-0.81/0.0009

Histone demethylase

Lc/Sc

TET1

11.9/7.1

-0.73/0.002

Functional demethylation

Lc

Class 2

ARID4A

12.5/9

-0.48/0.03

HDAC bridging molecule

Lc/Sc/Sptg/Sptc

ARID5B

21.6/15.3

-0.49/0.03

Histone demethylase

Lc/Sc/Sptg

ATRX

33.7/19.3

-0.79/0.002

Methyltransferase

Lc/Sc/Sptg

DNMT3A

24.6/19.86

n.s

Methyltransferase

LC/Sc/Sptg

EPC1

23.0/14.1

-0.7/0.002

Histone acetyltransferase

Lc/Sptg

HDAC1

22.2/12.7

-0.80/0.0008

Deacetylase

Lc/Sc/Sptg/Sptc

HDAC2

15.5/9.7

-0.67/0.004

Deacetylase

Lc/Sc/Sptg/Sptcs

HDAC3

22.2/16.2

-0.45/0.045

Deacetylase

Lc/Sc/Sptg

HDAC8

7.7/5.7

-0.48/0.052

Histone decrotonylase

Lc/Sc/Sptg

INO80D

12.1/7.9

-0.60/0.01

Chromatin remodeling

Lc/Sc/Sptg

KDM4A

27.6/20.3

-0.44/0.052

Histone demethylase

Lc/Sc/Sptg

KMT2E

35.8/24.2

-0.56/0.02

Methyltransferase

Lc/Sc/Sptg

PBRM1

27.2/16.6

-0.7/0.004

Chromatin remodeling

Lc/Sc/Sptg/Sptc

PRMT2

27.5/16.9

-0.69/0.004

Arginine methyltransferase

Lc/Sc/Sptg

SETD7

22.3/12.3

-0.85/0.0006

Methyl transferase

Lc/Sc/Sptg

SMARCA1

96.2/52.6

-0.87/0.0004

Chromatin regulator

Lc/Sc/Sptg

SMARCA2

37.3/24.0

-0.87/0.0009

Chromatin regulator

Lc/Sc/Sptg

TSPYL4

12.4/9.2

-0.43/0.054

Chromatin and histone binding

Lc/Sc/Sptg/Sptc

Class 3

ARID2

19.3/11.6

-0.72/0.003

Chromatin remodeling

Sptd/Sptc

ASH1L

43.3/36.8

-0.62/0.01

Methyltransferase

Sptg/Sptc

BAZ2B

47.0/27.6

-0.76/0.003

Chromatin remodeling

Sptc/Sptd

SCML2

26.3/14.5

-0.85/0.0005

Histone transcriptional repressor

Sptg/Sptc

SETD2

40.0/24.5

-0.7/0.005

Methyltransferase

Sptg/Sptc

TRDMT1

4.89/3.5

-0.45/0.048

Methyltransferase

Sptc

  1. RNA-Seq data are indicated for biopsies from high/low infertility risk patients before (-) and after ( +) GnRH treatment. RNA levels (reads per kilobase and million, RPKM), log2 fold changes (log2FC), and false discovery rates (FDRs) are given
  2. n.s. not significant, Lc Leydig cell, Sc Sertoli cell, Sptg spermatogonium, Sptc spermatocyte, Sptd spermatid